M. Dreyling

419 total citations
4 papers, 278 citations indexed

About

M. Dreyling is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, M. Dreyling has authored 4 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pathology and Forensic Medicine, 3 papers in Genetics and 3 papers in Oncology. Recurrent topics in M. Dreyling's work include Lymphoma Diagnosis and Treatment (4 papers), Viral-associated cancers and disorders (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). M. Dreyling is often cited by papers focused on Lymphoma Diagnosis and Treatment (4 papers), Viral-associated cancers and disorders (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). M. Dreyling collaborates with scholars based in Germany, Denmark and United Kingdom. M. Dreyling's co-authors include Julia Bohlius, Maximilian F. Reiser, Andreas Engert, Michael Hallek, Thilo Kober, Guido Schwarzer, Hermann Schulz, Sven Trelle, Nicole Skoetz and Jeanette K. Doorduijn and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Annals of Oncology and Hematology.

In The Last Decade

M. Dreyling

2 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Dreyling Germany	2	246	182	135	41	38	4	278
Maya Hacini France	6	285 1.2×	189 1.0×	114 0.8×	31 0.8×	81 2.1×	15	358
Mark D. Sborov United States	6	166 0.7×	184 1.0×	88 0.7×	51 1.2×	32 0.8×	8	254
M. van ‘t Veer Netherlands	4	209 0.8×	161 0.9×	124 0.9×	27 0.7×	32 0.8×	5	278
Viola Pöschel Germany	7	235 1.0×	186 1.0×	75 0.6×	32 0.8×	108 2.8×	8	293
John C. Byrd United States	4	251 1.0×	182 1.0×	106 0.8×	54 1.3×	43 1.1×	4	288
Hanne Kuitunen Finland	12	270 1.1×	168 0.9×	157 1.2×	43 1.0×	92 2.4×	45	380
Georg Lenz Germany	2	240 1.0×	184 1.0×	85 0.6×	15 0.4×	33 0.9×	2	265
Alessandra Dondi Italy	6	205 0.8×	171 0.9×	75 0.6×	16 0.4×	39 1.0×	14	255
C. Klinkenstein Germany	2	344 1.4×	258 1.4×	177 1.3×	31 0.8×	46 1.2×	2	386
Antonella Anastasia Italy	10	216 0.9×	161 0.9×	78 0.6×	44 1.1×	92 2.4×	21	284

Countries citing papers authored by M. Dreyling

Since Specialization

Citations

This map shows the geographic impact of M. Dreyling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Dreyling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Dreyling more than expected).

Fields of papers citing papers by M. Dreyling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Dreyling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Dreyling. The network helps show where M. Dreyling may publish in the future.

Co-authorship network of co-authors of M. Dreyling

This figure shows the co-authorship network connecting the top 25 collaborators of M. Dreyling. A scholar is included among the top collaborators of M. Dreyling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Dreyling. M. Dreyling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Dreyling, M., et al.. (2025). First Line Therapy in Mantle Cell Lymphoma—The Role of BTKi in the Initial Treatment of Transplant‐Eligible and ‐Ineligible Patients. Hematological Oncology. 43(S2). e70073–e70073.

2.

Dreyling, M., et al.. (2024). To consolidate or not to consolidate: the role of autologous stem cell transplantation in MCL. Hematology. 2024(1). 42–47.

3.

Ferreri, Andrés J.M., Gerald Illerhaus, Jeanette K. Doorduijn, et al.. (2024). Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of Oncology. 35(6). 491–507. 10 indexed citations

4.

Schulz, Hermann, Julia Bohlius, Sven Trelle, et al.. (2007). Immunochemotherapy With Rituximab and Overall Survival in Patients With Indolent or Mantle Cell Lymphoma: A Systematic Review and Meta-analysis. JNCI Journal of the National Cancer Institute. 99(9). 706–714. 268 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact